Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC "unfairness" standard

This article was originally published in The Tan Sheet

Executive Summary

Nonprescription Drug Manufacturers Association is part of a 36-member coalition that sent a Feb. 15 letter to all conferees working on Federal Trade Commission reauthorization legislation (HR 2243). The letter, also signed by the Cosmetic, Toiletry and Fragrance Association, urges support of "continued restrictions on the FTC's unfairness authority for advertising" and supports a Senate version of the bill, which makes permanent a ban on FTC's use of unfairness rulemaking authority for ads. The House bill places no restrictions on FTC's rulemaking authority ("The Tan Sheet" Sept. 27, 1993, In Brief)
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082511

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel